Forced Registration Makes Flimsy Suit, Mylan Tells Fed. Circ.
Mylan Pharmaceuticals pushed a Federal Circuit panel on Monday to toss a Delaware federal suit alleging it violated rival Acorda's drug patents with a generic drug application, maintaining the state's mandatory...To view the full article, register now.
Already a subscriber? Click here to view full article